Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Delta9-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells. Involvement of CB1 cannabinoid receptor and Raf-1

  • Velasco Davoise, Lara|||0000-0002-6608-5938
  • Ruiz Llorente, Lidia|||0000-0003-1430-9618
  • Sánchez, María G.
  • Díaz-Laviada Marturet, Inés Cecilia|||0000-0001-9704-4373
5 p., We show that addition of Δ9-tetrahydrocanna binol to PC-3 cells stimulated nerve growth factor production in a dose-dependent and time-dependent manner. Maximal effect was observed at 0.1 microM Δ9-tetra hydrocannabinol and 72 h of treatment. Stimulation was reversed by the CB1 antagonists AM 251 and SR 1411716A. Pre-treatment of cells with pertussis toxin also prevented the effect promoted by Δ9-tetrahydrocanna binol. These results indicate that Δ9-tetrahydrocannabinol stimulation of nerve growth factor production in these cells was mediated by the cannabinoid CB1 receptor. The implication of Raf-1 activation in the mode of action of D9-tetrahydrocannabinol is also suggested., Ministerio de Educación y Cultura, Junta de Comunidades de Castilla-La Mancha
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism

  • Ruiz Llorente, Lidia|||0000-0003-1430-9618
  • Miguel, Alberto
  • Díaz-Laviada Marturet, Inés Cecilia|||0000-0001-9704-4373
5 p., The effect of Delta9-tetrahydrocannabinol (THC), the major psycho-active component of marijuana, in human prostate cancer cells PC-3 was investigated. THC caused apoptosis in a dose-dependent manner. Morphological and biochemical changes induced by THC in prostate PC-3 cells shared the characteristics of an apoptotic phenomenon. First, loss of plasma membrane asymmetry determined by fluorescent anexin V binding. Second, presence of apoptotic bodies and nuclear fragmentation observed by DNA staining with 4?,6-diamino-2-phenylindole (DAPI). Third, presence of typical ?ladder-patterned? DNA fragmentation. Central cannabinoid receptor expression was observed in PC-3 cells by immunofluorescence studies. However, several results indicated that the apoptotic effect was cannabinoid receptor-independent, such as lack of an effect of the potent cannabinoid agonist WIN 55,212-2, inability of cannabinoid antagonist AM 251 to prevent cellular death caused by THC and absence of an effect of pertussis toxin pre-treatment., Universidad de Alcalá, Ministerio de Educación, Cultura y Deporte
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Expression of functionally active cannabinoid receptor CB1 in the human prostate gland

  • Ruiz Llorente, Lidia|||0000-0003-1430-9618
  • Sánchez Alonso, María de Gracia
  • Carmena Sierra, María José|||0000-0002-5602-0014
  • Prieto Villapún, Juan Carlos
  • Sánchez Chapado, Manuel Vicente|||0000-0003-3317-4544
  • Izquierdo Lahuerta, Adriana
  • Díaz-Laviada Marturet, Inés Cecilia|||0000-0001-9704-4373
8 p., Background: Cannabinoids exert a wide spectrum of effects in men including alterations in the reproductive system. To date, two types of cannabinoid receptors have been cloned in humans, namely CB(1) and CB(2) belonging to the G protein-coupled receptor superfamily. Although cannabinoids have functional and morphologic effects in the prostate gland, the expression of cannabinoid receptors in this tissue has never been investigated. The aim of this study was to analyze the expression of cannabinoid receptors in the human prostate gland and their regulatory effects on adenylyl cyclase activity. Methods: To investigate the existence of cannabinoid receptors in prostate, we used various methods, including reverse transcriptase-polymerase chain reaction, Western blotting, and immunohistochemistry. Adenylyl cyclase activity was analyzed by measuring the cAMP produced by means of a competitive assay by using PKA. Results: Both mRNA for CB(1) and the corresponding protein are expressed in the human prostate gland at a level comparable with the receptor expressed in cerebellum. The molecular mass of the protein estimated from Western blot analysis was 58 kDa, which is in concordance with previous data for CB(1) in other tissues. Immunohistochemical studies show that CB(1) is preferentially expressed in the epithelia of the prostate. The cannabinoid receptor expressed in the prostate negatively regulates adenylyl cyclase activity through a pertussis toxin-sensitive protein., Ministerio de Educación, Cultura y Deporte